UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

                Date of Report (Date of earliest event reported):
                         April 16, 2007 (April 10, 2007)


                              DELCATH SYSTEMS, INC.
             (Exact name of registrant as specified in its charter)

    DELAWARE                         001-16133                    06-1245881
(State of incorporation)        (Commission File No.)           (IRS Employer
                                                             Identification No.)

                 1100 SUMMER STREET, STAMFORD, CONNECTICUT 06905
          (Address of principal executive offices, including zip code)

                                 (203) 323-8668
              (Registrant's telephone number, including area code)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
    230.425)

[ ] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
    240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
    Act (17CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
    Act (17 CFR 240.13e-4(c))


                                       1




ITEM 1.01- ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

On April 10, 2007, Delcath Systems,  Inc. (the "Company") issued a press release
stating that it has entered into a  Modification  Agreement  (the  "Modification
Agreement")  with Laddcap  Value  Partners,  LP,  Laddcap  Associates,  LLC, and
Laddcap  Value  Associates,   LLC  (collectively  "Laddcap").  The  Modification
Agreement  amends the  October 8, 2006  Settlement  Agreement  (the  "Settlement
Agreement")  previously  entered  into by the  Company  with  Laddcap and allows
Laddcap to increase its position in the Company,  through open market  purchases
of the Company's shares, beyond the previous 14.9% limitation  established under
the  Settlement  Agreement to just under 20%. The  Modification  Agreement  also
provides  that the Company  will no longer be  required  to elect two  directors
nominated  by Laddcap or to appoint at least one Laddcap  nominee to each of its
committees, as stipulated in the Settlement Agreement. The Board of Directors of
the  Company  also  voted  unanimously  to  increase  the  threshold  level  for
triggering  the  Shareholder  Rights  Plan  ("Rights  Plan")  from  15% to  20%,
effective immediately.

ITEM 9.01         FINANCIAL STATEMENTS AND EXHIBITS.

(a)      NOT APPLICABLE.
(b)      NOT APPLICABLE.
(c)      NOT APPLICABLE.

(d) EXHIBITS.

         EXHIBIT NO.           DESCRIPTION
       --------------          -------------

            10.1               Modification Agreement dated April 9, 2007
            99.1               Press Release dated April 10, 2007

                                       2




                                    SIGNATURE

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned.

Dated:  April 16, 2007                           DELCATH SYSTEMS, INC.


                                                 By: /s/ Richard L. Taney
                                                     --------------------
                                                     Richard L. Taney
                                                     Chief Executive Officer


                                       3
                             MODIFICATION AGREEMENT

     MODIFICATION  AGREEMENT,  dated  as of April 9,  2007  (this  "MODIFICATION
AGREEMENT")  by and  between  DELCATH  SYSTEMS,  INC.,  a  Delaware  corporation
("DELCATH"),  and LADDCAP  VALUE  PARTNERS LP, a Delaware  limited  partnership,
LADDCAP  ASSOCIATES LLC, a Delaware  limited  liability  company,  LADDCAP VALUE
ASSOCIATES LLC, a Delaware limited liability company,  any affiliate (as defined
under the Securities  Exchange Act of 1934, as amended) of any of the foregoing,
and Mr.  ROBERT B. LADD  ("LADD"),  in his  individual  capacity  (collectively,
"LADDCAP," and together with Delcath, the "PARTIES").

     WHEREAS, Delcath and Laddcap are parties to a Settlement Agreement dated as
of October 8, 2006 (the "SETTLEMENT AGREEMENT"); and

     WHEREAS,  the parties  agree that the issues which led the Parties to enter
into the Settlement  Agreement have been largely resolved,  that continuation of
most covenants  under the Agreement  serve no valuable  purposes for the Parties
and certain of such covenants  unnecessarily  restrict the Parties activities at
little or no benefit to the counter-parties; and

     WHEREAS,  the  Parties  have  accordingly  agreed to modify the  Settlement
Agreement  with respect to certain  obligations  and rights of the Parties under
the Settlement Agreement;

     NOW,   THEREFORE,   in  consideration  of  the  mutual  execution  of  this
Modification  Agreement and the mutual agreements set forth herein,  the Parties
hereby agree as follows:

     1. Except as otherwise expressly set forth in this Modification  Agreement,
Laddcap and the Company hereby  release one another from all future  obligations
created  under the  Settlement  Agreement,  with the  exception  of the Parties'
obligations pursuant to Sections 5 and 6.

     2. The provisions of Section 13 of the Settlement Agreement shall remain in
force.

     3. In accordance  with Section 13(k) of the Settlement  Agreement,  Delcath
hereby  designates  the  following as the address to which all notices and other
communications  to it  under  the  Settlement  Agreement  or  this  Modification
Agreement shall be given:

                          Delcath Systems, Inc.
                          1100 Summer Street
                          Stamford, Connecticut 06905
                          Attention: Chief Executive Officer
                          Facsimile: (203) 961-0120

No copy of any  such  notice  or  other  communication  to  Delcath  needs to be
delivered to any other person.

     4. This Modification Agreement may be executed in two or more counterparts,
all of which shall be considered as one and the same instrument and shall become
effective when one or more  counterparts have been signed by each of the Parties
and delivered to the other party.



                                                                               2


     5. This Modification Agreement may be executed by facsimile signature,  and
a facsimile signature shall constitute an original for all purposes.

     IN WITNESS  WHEREOF,  the Parties  hereto have executed  this  Modification
Agreement as of the date first above written.


                                   LADDCAP VALUE PARTNERS LP

                                   By LADDCAP VALUE ASSOCIATES LLC,
                                   Its General Partner

                                   By:  /s/ Robert B. Ladd
                                       -------------------------------
                                        Name: Robert B. Ladd
                                        Title: Managing Member


                                   LADDCAP VALUE ASSOCIATES LLC

                                   By:  /s/ Robert B. Ladd
                                       -------------------------------
                                        Name: Robert B. Ladd
                                        Title: Managing Member


                                   LADDCAP VALUE ADVISORS LLC

                                   By:  /s/ Robert B. Ladd
                                       -------------------------------
                                        Name: Robert B. Ladd
                                        Title: Managing Member


                                   ROBERT B. LADD

                                      /s/ Robert B. Ladd
                                   ----------------------------------
                                      Robert B. Ladd


                                   DELCATH SYSTEMS, INC.

                                   By:  /s/ Richard Taney
                                       -------------------------------
                                        Name: Richard Taney
                                        Title: Interim Chief Executive Officer

[DELCATH SYSTEMS LOGO]                                              EXHIBIT 99.1





COMPANY CONTACT:                            INVESTOR RELATIONS CONTACTS:
Delcath Systems, Inc.                       Lippert/Heilshorn & Associates, Inc.
- ---------------------                       ------------------------------------
Richard Taney                               Anne Marie Fields
(203) 323-8668                              (afields@lhai.com)
www.delcath.com                             (212) 838-3777
                                            Bruce Voss (bvoss@lhai.com)
                                            (310) 691-7100
                                            www.lhai.com

LHA DRAFT 1
- -----------

               DELCATH SYSTEMS ENTERS MODIFICATION AGREEMENT WITH
                  LADDCAP AND MODIFIES STOCKHOLDER RIGHTS PLAN

                   ALLOWS LADDCAP TO INCREASE HOLDINGS TO 20%

STAMFORD,  CT,  APRIL 10,  2007--Delcath  Systems,  Inc.  (Nasdaq:  DCTH)  today
announced  that the Company  has  entered  into a  Modification  Agreement  with
Laddcap  Value  Partners,  LP,  Laddcap  Associates,   LLC,  and  Laddcap  Value
Associates, LLC (Collectively "Laddcap") to amend the October 8, 2006 Settlement
Agreement  between  Delcath  and  Laddcap.  The key  terms  of the  Modification
Agreement  will allow  Laddcap to increase  its  position  in Delcath,  if it so
chooses,  through open market  purchases of Delcath  shares  beyond the previous
14.9% limitation established by the October 8, 2006 settlement agreement to just
under  20%.  Furthermore,  Delcath  will no  longer  be  required  to elect  two
directors  nominated  by Laddcap or to appoint at least one  Laddcap  nominee to
each of its  committees as stipulated  in the original  agreement.  The Board of
Directors of Delcath also voted  unanimously to increase the threshold level for
triggering  the  Shareholder  Rights  Plan  ("Rights  Plan")  from  15% to  20%,
effective immediately.

Mr.  Richard L. Taney,  Chief  Executive  Officer of Delcath,  commented  on the
amended  agreement,  "We are pleased to have  modified the  original  Settlement
Agreement  with Laddcap and believe that this  Modification  Agreement  benefits
both  Delcath  and  its  stockholders.   The  board  undertook  this  action  in
recognition of the changed  circumstances  and position of the company today. In
addition,  we have  amended  the  Company's  "Rights  Plan" to raise the trigger
threshold  under the plan for all  stockholders  to the same level  approved for
Laddcap,  which is just under 20%.  We view the  raising  of the  threshold  for
triggering  the  rights  plan  as  a  stockholder-friendly   step,  while  still
maintaining the Boards flexibility to enhance  shareholder value in case the 20%
threshold is crossed."

"With the recently announced  expansion to our Clinical Research and Development
Agreement  ("CRADA") with the National Cancer Institute  ("NCI") and our planned



expansion of the pivotal Phase III trial of the Company's  Delcath System into a
multi-center  trial,  we  continue  to  move  forward  towards  our  goal of the
commercialization  of  our  percutaneous  perfusion  technology  for  organ  and
region-specific delivery of therapeutic and chemotherapeutic agents."

Delcath  Board member  Robert Ladd,  who is also the Managing  Member of Laddcap
Value  Partners,  stated,  I am very  pleased  with the amended  agreement.  All
shareholders  should applaud this step toward improved corporate  governance and
transparency."

ABOUT DELCATH SYSTEMS, INC.

Delcath Systems is a developer of percutaneous perfusion technology for organ or
region-specific   delivery  of  therapeutic  and  chemotherapeutic  agents.  The
Company's  intellectual property portfolio currently consists of 12 patents on a
worldwide basis,  including the United States, Europe, Asia and Canada. For more
information, please visit the Company's website, www.delcath.com.

THIS RELEASE CONTAINS FORWARD-LOOKING  STATEMENTS,  WHICH ARE SUBJECT TO CERTAIN
RISKS AND UNCERTAINTIES  THAT CAN CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM
THOSE DESCRIBED.  FACTORS THAT MAY CAUSE SUCH DIFFERENCES  INCLUDE,  BUT ARE NOT
LIMITED TO, UNCERTAINTIES RELATING TO OUR ABILITY TO SUCCESSFULLY COMPLETE PHASE
III  CLINICAL  TRIALS AND SECURE  REGULATORY  APPROVAL  OF OUR CURRENT OR FUTURE
DRUG-DELIVERY SYSTEM AND UNCERTAINTIES REGARDING OUR ABILITY TO OBTAIN FINANCIAL
AND  OTHER  RESOURCES  FOR  ANY  RESEARCH,   DEVELOPMENT  AND  COMMERCIALIZATION
ACTIVITIES.  THESE FACTORS,  AND OTHERS,  ARE DISCUSSED FROM TIME TO TIME IN OUR
FILINGS WITH THE SECURITIES AND EXCHANGE COMMISSION.  YOU SHOULD NOT PLACE UNDUE
RELIANCE ON THESE  FORWARD-LOOKING  STATEMENTS,  WHICH SPEAK ONLY AS OF THE DATE
THEY ARE MADE.  WE UNDERTAKE NO  OBLIGATION  TO PUBLICLY  UPDATE OR REVISE THESE
FORWARD-LOOKING  STATEMENTS TO REFLECT  EVENTS OR  CIRCUMSTANCES  AFTER THE DATE
THEY ARE MADE.

                                      # # #